180 related articles for article (PubMed ID: 24649292)
1. Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen.
Leão RB; Andrade L; Vassalo J; Antunes A; Pinto-Neto A; Costa-Paiva L
Mol Clin Oncol; 2013 Nov; 1(6):1055-1060. PubMed ID: 24649292
[TBL] [Abstract][Full Text] [Related]
2. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients.
Antunes A; Vassallo J; Pinheiro A; Leão R; Neto AM; Costa-Paiva L
Oncol Lett; 2014 Jun; 7(6):1944-1950. PubMed ID: 24932265
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
6. K-ras mutation in tamoxifen-related endometrial polyps.
Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
[TBL] [Abstract][Full Text] [Related]
7. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.
Mourits MJ; Ten Hoor KA; van der Zee AG; Willemse PH; de Vries EG; Hollema H
J Clin Pathol; 2002 Jul; 55(7):514-9. PubMed ID: 12101196
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptor expression in endometria from women treated with tamoxifen.
Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of symptomatic postmenopausal endometrial polyps in tamoxifen users and nonusers: a case control study.
Dibi RP; Zettler CG; Vanin CMM; Ribeiro RVP; Oliveira JM; Kremer TG; Borges J; Kato SK
Sao Paulo Med J; 2020; 138(1):64-68. PubMed ID: 32215462
[TBL] [Abstract][Full Text] [Related]
11. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
de Carvalho S; Campaner AB; Lima SM; Silva MA; Ribeiro PA
Anal Quant Cytol Histol; 2011 Apr; 33(2):61-7. PubMed ID: 21980607
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptor expression in endometrial polyps.
Mittal K; Schwartz L; Goswami S; Demopoulos R
Int J Gynecol Pathol; 1996 Oct; 15(4):345-8. PubMed ID: 8886882
[TBL] [Abstract][Full Text] [Related]
14. Effect of tamoxifen on postmenopausal endometrium.
Kalampokas T; Sofoudis C; Anastasopoulos C; Boutas I; Melloy S; Kondi-Pafiti A; Kalampokas E; Botsis D; Salakos N
Eur J Gynaecol Oncol; 2013; 34(4):325-8. PubMed ID: 24020139
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
17. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index.
Belisário MS; Vassallo J; Andrade LA; Alvarenga M; Pinto GA; Monteiro IM
Maturitas; 2006 Jan; 53(1):114-8. PubMed ID: 15894442
[TBL] [Abstract][Full Text] [Related]
18. Alterations in steroid hormone receptors in the tamoxifen-treated endometrium.
Schwartz LB; Krey L; Demopoulos R; Goldstein SR; Nachtigall LE; Mittal K
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):129-37. PubMed ID: 9024103
[TBL] [Abstract][Full Text] [Related]
19. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
